Loading clinical trials...
Loading clinical trials...
A Phase 2, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study Evaluating the Efficacy and Safety of VX-993 for Acute Pain After a Bunionectomy
Conditions
Interventions
VX-993
HB/APAP
+2 more
Locations
14
United States
Shoals Medical Trials Inc.
Sheffield, Alabama, United States
Arizona Research Center
Phoenix, Arizona, United States
Woodland International Research Group
Little Rock, Arkansas, United States
Trovare Clinical Research
Bakersfield, California, United States
New Hope Research Development | Tarzana, CA
Tarzana, California, United States
Clinical Pharmacology of Miami
Miami, Florida, United States
Start Date
October 29, 2024
Primary Completion Date
May 27, 2025
Completion Date
May 27, 2025
Last Updated
June 26, 2025
NCT07422272
NCT07310953
NCT06184126
NCT07256548
NCT05335070
NCT03725527
Lead Sponsor
Vertex Pharmaceuticals Incorporated
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions